Motilal Oswal on Cholamandalam Investment Cobrapost Claims refusal: Motilal Oswal retains a Buy rating on Cholamandalam ...
With an estimated 51.5 million U.S. adults suffering from mental illness and the psychedelic drug market projected to grow at a 15% CAGR to nearly $13 billion by 2035 ・Both Compass Pathways and Mind ...